508 related articles for article (PubMed ID: 16357343)
21. The Delta intracellular domain mediates TGF-beta/Activin signaling through binding to Smads and has an important bi-directional function in the Notch-Delta signaling pathway.
Hiratochi M; Nagase H; Kuramochi Y; Koh CS; Ohkawara T; Nakayama K
Nucleic Acids Res; 2007; 35(3):912-22. PubMed ID: 17251195
[TBL] [Abstract][Full Text] [Related]
22. Antisense targeting of TGF-beta1 augments BMP-induced upregulation of osteopontin, type I collagen and Cbfa1 in human Saos-2 cells.
Shen ZJ; Kim SK; Jun DY; Park W; Kim YH; Malter JS; Moon BJ
Exp Cell Res; 2007 Apr; 313(7):1415-25. PubMed ID: 17359969
[TBL] [Abstract][Full Text] [Related]
23. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
Onichtchouk D; Chen YG; Dosch R; Gawantka V; Delius H; Massagué J; Niehrs C
Nature; 1999 Sep; 401(6752):480-5. PubMed ID: 10519551
[TBL] [Abstract][Full Text] [Related]
24. 5-azacytidine alters TGF-beta and BMP signaling and induces maturation in articular chondrocytes.
Zuscik MJ; Baden JF; Wu Q; Sheu TJ; Schwarz EM; Drissi H; O'Keefe RJ; Puzas JE; Rosier RN
J Cell Biochem; 2004 May; 92(2):316-31. PubMed ID: 15108358
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
26. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
27. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
Tanaka T; Toujima S; Umesaki N
Oncol Rep; 2004 Apr; 11(4):875-9. PubMed ID: 15010888
[TBL] [Abstract][Full Text] [Related]
28. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
Keah HH; Hearn MT
J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132
[TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of mouse mast cell protease-6 gene by transforming growth factor-beta and activin in mast cell progenitors.
Funaba M; Ikeda T; Murakami M; Ogawa K; Abe M
Cell Signal; 2005 Jan; 17(1):121-8. PubMed ID: 15451032
[TBL] [Abstract][Full Text] [Related]
31. Bone morphogenetic protein (BMP)-7 but not BMP-2 and BMP-4 improves maintenance of primitive peripheral blood-derived hematopoietic progenitor cells (HPC) cultured in serum-free medium supplemented with early acting cytokines.
Grassinger J; Simon M; Mueller G; Drewel D; Andreesen R; Hennemann B
Cytokine; 2007 Dec; 40(3):165-71. PubMed ID: 18029192
[TBL] [Abstract][Full Text] [Related]
32. The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells.
Mabuchi Y; Yamoto M; Minami S; Umesaki N
Oncol Rep; 2006 Aug; 16(2):373-9. PubMed ID: 16820918
[TBL] [Abstract][Full Text] [Related]
33. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.
Miyoshi T; Otsuka F; Suzuki J; Takeda M; Inagaki K; Kano Y; Otani H; Mimura Y; Ogura T; Makino H
Biol Reprod; 2006 Jun; 74(6):1073-82. PubMed ID: 16436528
[TBL] [Abstract][Full Text] [Related]
34. Developmental pattern of expression of BMP receptors and Smads and activation of Smad1 and Smad5 by BMP9 in mouse basal forebrain.
Lopez-Coviella I; Mellott TM; Kovacheva VP; Berse B; Slack BE; Zemelko V; Schnitzler A; Blusztajn JK
Brain Res; 2006 May; 1088(1):49-56. PubMed ID: 16626664
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta signaling in embryonic stem cell-derived endothelial cells.
Watabe T; Yamashita JK; Mishima K; Miyazono K
Methods Mol Biol; 2006; 330():341-51. PubMed ID: 16846035
[TBL] [Abstract][Full Text] [Related]
36. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
Mazerbourg S; Hsueh AJ
Hum Reprod Update; 2006; 12(4):373-83. PubMed ID: 16603567
[TBL] [Abstract][Full Text] [Related]
37. Quiescence of hematopoietic stem cells and maintenance of the stem cell pool is not dependent on TGF-beta signaling in vivo.
Larsson J; Blank U; Klintman J; Magnusson M; Karlsson S
Exp Hematol; 2005 May; 33(5):592-6. PubMed ID: 15850837
[TBL] [Abstract][Full Text] [Related]
38. Activin A balances Sertoli and germ cell proliferation in the fetal mouse testis.
Mendis SH; Meachem SJ; Sarraj MA; Loveland KL
Biol Reprod; 2011 Feb; 84(2):379-91. PubMed ID: 20926807
[TBL] [Abstract][Full Text] [Related]
39. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.
Hendy GN; Kaji H; Sowa H; Lebrun JJ; Canaff L
Horm Metab Res; 2005 Jun; 37(6):375-9. PubMed ID: 16001330
[TBL] [Abstract][Full Text] [Related]
40. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling.
Sumi T; Tsuneyoshi N; Nakatsuji N; Suemori H
Development; 2008 Sep; 135(17):2969-79. PubMed ID: 18667462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
